The Homogeneity of Lupus Nephritis Patients

Lily has walked away from the drug and lupus after failing with phase three. It's very difficult for us to get access to double dose B lillimimab, which is what you need for lupus nephritis because of the cost. We don't have yet publicly reimbursed in Canada. So I think right now it's like, okay, if we have to, it might be something we might consider. The population that they're doing this, right? It's very homogenous there, but I don't know if it'll be reflected when it's like,. you know, African Americans more, or I don’t know, like with Caucas